An electronic pressure-meter nociception paw test for rats.
暂无分享,去创建一个
F. Cunha | W. Verri | C. Parada | S. Ferreira | T. Cunha | S H Ferreira | F Q Cunha | S. Reis | W. Verri | G G Vivancos | W A Verri | T M Cunha | I R S Schivo | C A Parada | I. R. Schivo | T. M. Cunha | G. G. Vivancos | I. Moreira | I. F. Moreira
[1] F. Cunha,et al. Cytokine‐mediated inflammatory hyperalgesia limited by interleukin‐1 receptor antagonist , 2000, British journal of pharmacology.
[2] F. Cunha,et al. Bradykinin release of TNF-α plays a key role in the development of inflammatory hyperalgesia , 2005, Agents and Actions.
[3] F. Cunha,et al. Tumour necrosis factor-α, interleukin-1β and interleukin-8 induce persistent mechanical nociceptor hypersensitivity , 2002, Pain.
[4] K. Ä. Möller,et al. Assessing mechanical allodynia in the rat paw with a new electronic algometer , 1998, Journal of Neuroscience Methods.
[5] D. Dubuisson,et al. The formalin test: A quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats , 1977, Pain.
[6] J. Mogil,et al. Transgenic studies of pain , 1998, Pain.
[7] W. A. Prado,et al. The dual effect of a nitric oxide donor in nociception , 2001, Brain Research.
[8] F. Menniti,et al. Antinociceptive activity of CP‐101,606, an NMDA receptor NR2B subunit antagonist , 1997, British journal of pharmacology.
[9] S. Ferreira,et al. A peripheral sympathetic component in inflammatory hyperalgesia. , 1987, European journal of pharmacology.
[10] S. Ferreira,et al. Induction, blockade and restoration of a persistent hypersensitive state , 1990, Pain.
[11] S. Ferreira,et al. Central and peripheral antialgesic action of aspirin-like drugs. , 1978, European journal of pharmacology.
[12] S. Ferreira,et al. Molecular base of acetylcholine and morphine analgesia. , 1991, Agents and actions. Supplements.
[13] S. Ferreira,et al. Glutamate spinal retrograde sensitization of primary sensory neurons associated with nociception , 1994, Neuropharmacology.
[14] F. Cunha,et al. Interleukin‐8 as a mediator of sympathetic pain , 1991, British journal of pharmacology.
[15] J. Levine,et al. Opioid and adenosine peripheral antinociception are subject to tolerance and withdrawal , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[16] S. Ferreira,et al. Opposite nociceptive effects of the arginine/NO/cGMP pathway stimulation in dermal and subcutaneous tissues , 2003, British journal of pharmacology.
[17] S. Ferreira,et al. Activation of the arginine-nitric oxide pathway in primary sensory neurons contributes to dipyrone-induced spinal and peripheral analgesia , 1996, Inflammation Research.
[18] S. Ferreira,et al. Interleukin-1β as a potent hyperalgesic agent antagonized by a tripeptide analogue , 1988, Nature.
[19] Koichii Tanaka,et al. A mouse model of neuropathic cancer pain , 2002, PAIN.
[20] S. Ferreira,et al. I - Prostaglandin hyperalgesia, a cAMP/Ca2+ dependent process. , 1979, Prostaglandins.
[21] J. Greenspan,et al. Thresholds for the perception of sharpness and mechanical pain , 1990, Pain.
[22] W. Gispen,et al. Antagonism of the Melanocortin System Reduces Cold and Mechanical Allodynia in Mononeuropathic Rats , 2000, The Journal of Neuroscience.
[23] V. Granados-Soto,et al. Evidence for a peripheral mechanism of action for the potentiation of the antinociceptive effect of morphine by dipyrone. , 1999, Journal of pharmacological and toxicological methods.
[24] J. Truax,et al. Quantitative comparison of the analgesic and anti-inflammatory activities of aspirin, phenacetin and acetaminophen in rodents. , 1976, European journal of pharmacology.
[25] F. Cunha,et al. Tumour necrosis factor-alpha, interleukin-1beta and interleukin-8 induce persistent mechanical nociceptor hypersensitivity. , 2002, Pain.
[26] F. Cunha,et al. Pharmacological modulation of secondary mediator systems–cyclic AMP and cyclic GMP–on inflammatory hyperalgesia , 1999, British journal of pharmacology.
[27] D Le Bars,et al. Animal models of nociception. , 2001, Pharmacological reviews.
[28] P. Crutzen,et al. Phosgene measurements in the upper troposphere and lower stratosphere , 1988, Nature.
[29] A. Pertovaara,et al. The Mechanical Antihyperalgesic Effect of Intrathecally Administered MPV-2426, a Novel &agr;2-Adrenoceptor Agonist, in a Rat Model of Postoperative Pain , 2000, Anesthesiology.
[30] F. Cunha,et al. The pivotal role of tumour necrosis factor alpha in the development of inflammatory hyperalgesia. , 1992, British journal of pharmacology.
[31] S. Ferreira,et al. Participation of the sympathetic system in acetic acid-induced writhing in mice. , 1988, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.
[32] Ulf Lindblom,et al. Pressure-pain threshold in human temporal region. Evaluation of a new pressure algometer , 1986, Pain.
[33] F. Cunha,et al. Dual effect of local application of nitric oxide donors in a model of incision pain in rats. , 2002, European journal of pharmacology.
[34] H. Miranda,et al. NSAID antinociception measured in a chemical and a thermal assay in mice. , 2001, Pain research & management.
[35] I. Duarte,et al. Involvement of ATP-sensitive K(+) channels in the peripheral antinociceptive effect induced by dipyrone. , 2002, European journal of pharmacology.
[36] K. Omote,et al. The Effects of Peripheral Administration of a Novel Selective Antagonist for Prostaglandin E Receptor Subtype EP1, ONO-8711, in a Rat Model of Postoperative Pain , 2001, Anesthesia and analgesia.
[37] T. Coderre. Contribution of protein kinase C to central sensitization and persistent pain following tissue injury , 1992, Neuroscience Letters.
[38] S. Ferreira,et al. Bradykinin initiates cytokine‐mediated inflammatory hyperalgesia , 1993, British journal of pharmacology.
[39] S. Ferreira,et al. Mode of analgesic action of dipyrone: direct antagonism of inflammatory hyperalgesia. , 1985, European journal of pharmacology.
[40] J. Vane,et al. Prostaglandins and the mechanism of analgesia produced by aspirin‐like drugs , 1997, British journal of pharmacology.
[41] R. Lo,et al. A method for measurement of analgesic activity on inflamed tissue. , 1957 .
[42] J. Vane,et al. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. , 1971, Nature: New biology.
[43] F. Cunha,et al. An electronic pressure-meter nociception paw test for mice. , 2004, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.
[44] B. Lynn,et al. Inhibition of forskolin-induced sensitisation of frog skin nociceptors by the cyclic AMP-dependent protein kinase A antagonist H-89 , 1998, Brain Research.
[45] Jin Mo Chung,et al. An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat , 1992, PAIN.
[46] H. Collier,et al. The abdominal constriction response and its suppression by analgesic drugs in the mouse. , 1968, British journal of pharmacology and chemotherapy.
[47] L. O. Randall,et al. A method for measurement of analgesic activity on inflamed tissue. , 1957, Archives internationales de pharmacodynamie et de therapie.
[48] J. Levine,et al. Contribution of guanine nucleotide regulatory proteins to prostaglandin hyperalgesia in the rat , 1989, Brain Research.